Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Summary

This phase II trial is studying selumetinib to see how well it works in treating patients with locally advanced or metastatic liver cancer. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.

Timeline

Start

2007-11

Primary completion

2012-06

Completion

2012-06

Drugs

Indications